Effects of opioid agonist and antagonist in dams exposed to morphine during the perinatal period

Brain Research Bulletin

Volumn 84, Issue 1, 2011, Pages 53-60

  Sobor, Melinda ^a,b   Timar, Julia ^b   Riba, Pal ^b   Friedmann, Tamas ^b   Király, Kornel P ^b   Gyarmati, Susanna ^b   Al Khrasani, Mahmoud ^b   Fürst, Susanna ^b,c  

^a National Institute of Pharmacy   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Dependence; Maternal behaviour; Morphine; Naloxone; Rat; Withdrawal

Indexed keywords

MORPHINE; NALOXONE; OPIATE AGONIST; OPIATE ANTAGONIST; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG EFFECT; DRUG WITHDRAWAL; EVALUATION; FEMALE; LOCOMOTION; MALE; MARE; MATERNAL BEHAVIOR; MATING; NONHUMAN; PERINATAL PERIOD; PHYSICAL ACTIVITY; PLACE PREFERENCE; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; RAT; REWARD; WEANING;

ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING, OPERANT; FEMALE; LACTATION; MALE; MATERNAL BEHAVIOR; MORPHINE; MOTOR ACTIVITY; NALOXONE; NARCOTIC ANTAGONISTS; NEUROPSYCHOLOGICAL TESTS; OPIOID-RELATED DISORDERS; PREGNANCY; RATS; RATS, WISTAR; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 78650306357     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2010.10.001     Document Type: Article

References (58)

1. Advokat C. Evidence of place conditioning after chronic intrathecal morphine in rats. Pharmacol. Biochem. Behav. 1985, 22:271-277.
2. Andrews Z.B., Grattan D.R. Opioid control of prolactin secretion in late pregnant rats is mediated by tuberoinfundibular dopamine neurons. Neurosci. Lett. 2002, 328:60-64.
3. Avila M.A., Ruggiero R.N., Cabral A., Brandao M.L., Nobre M.J., Castilho V.M. Involvement of the midbrain tectum in the unconditioned fear promoted by morphine withdrawal. Eur. J. Pharmacol. 2008, 590:217-223.
4. Bie B., Zhu W., Pan Z.Z. Rewarding morphine-induced synaptic function of delta-opioid receptors on central glutamate synapses. J. Pharmacol. Exp. Ther. 2009, 329:290-296.
5. Bridges R.S., Grimm C.T. Reversal of morphine disruption of maternal behavior by concurrent treatment with the opiate antagonist naloxone. Science 1982, 218:166-168.
6. Brunton P.J., Meddle S.L., Ma S., Ochedalski T., Douglas A.J., Russell J.A. Endogenous opioids and attenuated hypothalamic-pituitary-adrenal axis responses to immune challenge in pregnant rats. J. Neurosci. 2005, 25:5117-5126.
7. Brunton P.J., Russell J.A. The expectant brain: adapting for motherhood. Nat. Rev. 2008, 9:11-25.
8. Buckett W.R. A new test for morphine-like physical dependence (addiction liability) in rats. Psychopharmacologia 1964, 6:410-416.
9. Buckett W.R. Some pharmacological studies with 14-cinnamoyloxycodeinone. J. Pharm. Pharmacol. 1965, 17:759-760.
10. Byrnes E.M., Rigero B.A., Bridges R.S. Opioid receptor antagonism during early lactation results in the increased duration of nursing bouts. Physiol. Behav. 2000, 70:211-216.
11. Carboni E., Acquas E., Leone P., Di Chiara G. 5HT3 receptor antagonists block morphine- and nicotine- but not amphetamine-induced reward. Psychopharmacology 1989, 97:175-178.
12. Douglas A.J., Bicknell R.J., Leng G., Russell J.A., Meddle S.L. Beta-endorphin cells in the arcuate nucleus: projections to the supraoptic nucleus and changes in expression during pregnancy and parturition. J Neuroendocrinol. 2002, 14:768-777.
13. Fabian G., Bozo B., Szikszay M., Horvath G., Coscia C.J., Szucs M. Chronic morphine-induced changes in mu-opioid receptors and G proteins of different subcellular loci in rat brain. J. Pharmacol. Exp. Ther. 2002, 302:774-780.
14. Frenois F., Stinus L., Di Blasi F., Cador M., Le Moine C. A specific limbic circuit underlies opiate withdrawal memories. J. Neurosci. 2005, 25:1366-1374.
15. Fuchs R.A., See R.E. Basolateral amygdala inactivation abolishes conditioned stimulus- and heroin-induced reinstatement of extinguished heroin-seeking behavior in rats. Psychopharmacology 2002, 160:425-433.
16. Funada M., Schutz C.G., Shippenberg T.S. Role of delta-opioid receptors in mediating the aversive stimulus effects of morphine withdrawal in the rat. Eur. J. Pharmacol. 1996, 300:17-24.
17. Furst Z., Buzas B., Friedmann T., Schmidhammer H., Borsodi A. Highly potent novel opioid receptor agonist in the 14-alkoxymetopon series. Eur. J. Pharmacol. 1993, 236:209-215.
18. George S.R., Fan T., Xie Z., Tse R., Tam V., Varghese G., O'Dowd B.F. Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. J. Biol. Chem. 2000, 275:26128-26135.
19. Giacchino J.L., Henriksen S.J. Opioid effects on activation of neurons in the medial prefrontal cortex. Prog. Neuro-psychopharmacol. Biol. Psychiatry 1998, 22:1157-1178.
20. Gomes I., Filipovska J., Jordan B.A., Devi L.A. Oligomerization of opioid receptors. Methods (San Diego, Calif) 2002, 27:358-365.
21. Grimm C.T., Bridges R.S. Opiate regulation of maternal behavior in the rat. Pharmacol. Biochem. Behav. 1983, 19:609-616.
22. He S., Li N., Grasing K. Long-term opiate effects on amphetamine-induced dopamine release in the nucleus accumbens core and conditioned place preference. Pharmacol. Biochem. Behav. 2004, 77:327-335.
23. Hunt R.W., Tzioumi D., Collins E., Jeffery H.E. Adverse neurodevelopmental outcome of infants exposed to opiate in-utero. Early Hum. Dev. 2008, 84:29-35.
24. Irazusta J., Larrinaga G., Agirregoitia N., Varona A., Casis L. Effects of morphine administration and its withdrawal on rat brain aminopeptidase activities. Regul. Pept. 2003, 110:225-230.
25. Iwamoto E.T. Place-conditioning properties of mu, kappa, and sigma opioid agonists. Alcohol Drug Res. 1985, 6:327-339.
26. Jordan B.A, Devi L.A. G-protein-coupled receptor heterodimerization modulates receptor function. Nature 1999, 399:697-700.
27. Kinsley C.H., Bridges R.S. Opiate involvement in postpartum aggression in rats. Pharmacol. Biochem. Behav. 1986, 25:1007-1011.
28. Leng G., Dye S., Bicknell R.J. Kappa-opioid restraint of oxytocin secretion: plasticity through pregnancy. Neuroendocrinology 1997, 66:378-383.
29. Malfroy B., Swerts J.P., Guyon A., Roques B.P., Schwartz J.C. High-affinity enkephalin-degrading peptidase in brain is increased after morphine. Nature 1978, 276:523-526.
30. Mann P.E., Kinsley C.H., Bridges R.S. Opioid receptor subtype involvement in maternal behavior in lactating rats. Neuroendocrinology 1991, 53:487-492.
31. Miranda-Paiva C.M., Nasello A.G., Yin A.J., Felicio L.F. Morphine pretreatment increases opioid inhibitory effects on maternal behavior. Brain Res. Bull. 2001, 55:501-505.
32. Mucha R.F. Is the motivational effect of opiate withdrawal reflected by common somatic indices of precipitated withdrawal? A place conditioning study in the rat. Brain Res. 1987, 418:214-220.
33. Mucha R.F., van der Kooy D., O'Shaughnessy M., Bucenieks P. Drug reinforcement studied by the use of place conditioning in rat. Brain Res. 1982, 243:91-105.
34. Myers M.M., Brunelli S.A., Squire J.M., Shindeldecker R.D., Hofer M.A. Maternal behavior of SHR rats and its relationship to offspring blood pressures. Dev. Psychobiol. 1989, 22:29-53.
35. Nakagawa T., Yamamoto R., Fujio M., Suzuki Y., Minami M., Satoh M., Kaneko S. Involvement of the bed nucleus of the stria terminalis activated by the central nucleus of the amygdala in the negative affective component of morphine withdrawal in rats. Neuroscience 2005, 134:9-19.
36. Nieto M.M., Wilson J., Cupo A., Roques B.P., Noble F. Chronic morphine treatment modulates the extracellular levels of endogenous enkephalins in rat brain structures involved in opiate dependence: a microdialysis study. J. Neurosci. 2002, 22:1034-1041.
37. Numan M., Numan M.J., Pliakou N., Stolzenberg D.S., Mullins O.J., Murphy J.M., Smith C.D. The effects of D1 or D2 dopamine receptor antagonism in the medial preoptic area, ventral pallidum, or nucleus accumbens on the maternal retrieval response and other aspects of maternal behavior in rats. Behav. Neurosci. 2005, 119:1588-1604.
38. Numan M, Numan M.J., Schwarz J.M., Neuner C.M., Flood T.F., Smith C.D. Medial preoptic area interactions with the nucleus accumbens-ventral pallidum circuit and maternal behavior in rats. Behav. Brain Res. 2005, 158:53-68.
39. Olmstead M.C., Franklin K.B. The development of a conditioned place preference to morphine: effects of lesions of various CNS sites. Behav. Neurosci. 1997, 111:1313-1323.
40. Olmstead M.C., Franklin K.B. The development of a conditioned place preference to morphine: effects of microinjections into various CNS sites. Behav. Neurosci. 1997, 111:1324-1334.
41. Rayner V.C., Robinson I.C., Russell J.A. Chronic intracerebroventricular morphine and lactation in rats: dependence and tolerance in relation to oxytocin neurones. J. Physiol. 1988, 396:319-347.
42. Riba P., Ben Y., Smith A.P., Furst S., Lee N.M. Morphine tolerance in spinal cord is due to interaction between mu- and delta-receptors. J. Pharmacol. Exp. Ther. 2002, 300:265-272.
43. Schmitt U., Hiemke C. Combination of open field and elevated plus-maze: a suitable test battery to assess strain as well as treatment differences in rat behavior. Prog. Neuro-psychopharmacol. Biol. Psychiatry 1998, 22:1197-1215.
44. Schulteis G., Markou A., Gold L.H., Stinus L., Koob G.F. Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis. J. Pharmacol. Exp. Ther. 1994, 271:1391-1398.
45. Siddiqui A., Haq S., Shaharyar S., Haider S.G. Morphine induces reproductive changes in female rats and their male offspring. Reprod. Toxicol. (Elmsford, N.Y) 1995, 9:143-151.
46. Slamberova R., Szilagyi B., Vathy I. Repeated morphine administration during pregnancy attenuates maternal behavior. Psychoneuroendocrinology 2001, 26:565-576.
47. Sobor M., Timar J., Riba P., Kiraly K.P., Gyarmati S., Al-Khrasani M., Furst S. Does the effect of morphine challenge change on maternal behaviour of dams chronically treated with morphine during gestation and further on during lactation?. Pharmacol. Biochem. Behav. 2010, 95:367-374.
48. Solecki W., Ziolkowska B., Krowka T., Gieryk A., Filip M., Przewlocki R. Alterations of prodynorphin gene expression in the rat mesocorticolimbic system during heroin self-administration. Brain Res. 2009, 1255:113-121.
49. Terwilliger R.Z., Beitner-Johnson D., Sevarino K.A., Crain S.M., Nestler E.J. A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res. 1991, 548:100-110.
50. Timar J., Gyarmati Z., Furst Z. The development of tolerance to locomotor effects of morphine and the effect of various opioid receptor antagonists in rats chronically treated with morphine. Brain Res. Bull. 2005, 64:417-424.
51. Timar J., Sobor M., Kiraly K.P., Gyarmati S., Riba P., Al-Khrasani M., Furst S. Peri, pre and postnatal morphine exposure: exposure-induced effects and sex differences in the behavioural consequences in rat offspring. Behav. Pharmacol. 2010, 21:58-68.
52. Tjon G.H, De Vries T.J., Nestby P., Wardeh G., Mulder A.H., Schoffelmeer A.N. Intermittent and chronic morphine treatment induces long-lasting changes in delta-opioid receptor-regulated acetylcholine release in rat striatum and nucleus accumbens. Eur. J. Pharmacol. 1995, 283:169-176.
53. van Ree J.M., Gerrits M.A., Vanderschuren L.J. Opioids, reward and addiction: an encounter of biology, psychology, and medicine. Pharmacol. Rev. 1999, 51:341-396.
54. Wardlaw S.L., Frantz A.G. Brain beta-endorphin during pregnancy, parturition, and the postpartum period. Endocrinology 1983, 113:1664-1668.
55. White D.A, Hwang M.L., Holtzman S.G. Naltrexone-induced conditioned place aversion following a single dose of morphine in the rat. Pharmacol. Biochem. Behav. 2005, 81:451-458.
56. Wikler A., Norrell H., Miller D. Limbic system and opioid addiction in the rat. Exp. Neurol. 1972, 34:543-557.
57. Yim A.J., Miranda-Paiva C.M., Florio J.C., Oliveira C.A., Nasello A.G., Felicio L.F. A comparative study of morphine treatment regimen prior to mating and during late pregnancy. Brain Res. Bull. 2006, 68:384-391.
58. Zhang Z., Schulteis G. Withdrawal from acute morphine dependence is accompanied by increased anxiety-like behavior in the elevated plus maze. Pharmacol. Biochem. Behav. 2008, 89:392-403.